WELL Health: Canaccord Increases Price Target To $8.50 Following Bought Deal
This morning Canaccord Genuity raised their 12-month price target on WELL Health Technologies (TSX: WELL) to C$8.50 from C$8.00 and
Read moreThis morning Canaccord Genuity raised their 12-month price target on WELL Health Technologies (TSX: WELL) to C$8.50 from C$8.00 and
Read moreWELL Health Technologies (TSX: WELL) this morning continued with its healthcare consolidation strategy, announcing that it will be acquiring a
Read moreWELL Health Technologies (TSX: WELL) this morning announced yet another financing that is to be conducted by the firm. This
Read moreThis week WELL Health Technologies (TSX: WELL) announced that they are expanding into the US Market with a majority stake
Read moreWell Health Technologies (TSX: WELL) this morning announced that it is moving into the US market via the acquisition of
Read moreEarlier this month, WELL Health Technologies (TSX: WELL) reported their second quarter financials, with quarterly revenue coming in at $10.6
Read moreWELL Health Technologies (TSX: WELL) is returning to the trough again, this time under a bought deal arrangement with that
Read moreWELL Health Technologies Corp (TSX: WELL) has released its corporate update, in addition to providing a report on its healthcare services
Read moreWell Health Technologies (TSX: WELL) announced this morning that they have secured a convertible debenture financing from a single institutional
Read moreThe spread of the novel coronavirus, while not yet labelled a pandemic, has resulted in significant impacts to local communities
Read more